SEC Comment Letter 0000000000-24-010223 to Next Thing Technologies, Inc (CIK 0001897152)
Next Thing Technologies, Inc (CIK 0001897152)
Date: Sept. 10, 2024 · CIK: 0001897152 · Accession: 0000000000-24-010223
AI Filing Summary & Sentiment
File numbers found in text: 024-12260
Show Raw Text
September 10, 2024
Jason Adams
Chief Executive Officer
Next Thing Technologies, Inc
2180 Vista Way Unit B #1096
Oceanside, California 92054
Re:Next Thing Technologies, Inc
Post-Qualification Amendment No. 1 to Form 1-A
Filed on August 16, 2024
File No. 024-12260
Dear Jason Adams:
We have reviewed your amendment and have the following comment(s).
Please respond to this letter by amending your offering statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response. After
reviewing any amendment to your offering statement and the information you provide in response
to this letter, we may have additional comments.
Post-Qualification Amendment No. 1 to Form 1-A
Cover Page
1.Please revise your cover page and applicable risk factor to disclose the approximate
voting percentage that you expect your CEO to have assuming the maximum amount of
shares are sold in this offering. Also revise the risk factor on page 11 regarding voting
control.
Dilution, page 13
2.Please address the following as it relates to your dilution disclosures:
•Update the dilution table to reflect the information as of December 31, 2023 or the
most recent balance sheet date included in the filing.
•You appear to reflect the shares of common stock sold by selling shareholders as
newly issued shares in your dilution calculation. Exclude these shares from your
calculation as they appear to be already reflected in your historical number of shares.
September 10, 2024
Page 2
PLAN OF DISTRIBUTION AND SELLING SHAREHOLDERS, page 15
3.We note the link you provide to your Offering Circular is not active
(https://nextthing.tech/filings). We also note that the link to the Offering Circular on your
Web site is to the original circular, not the recent post-qualification amendment. Please
provide an updated link.
THE COMPANY'S BUSINESS, page 22
4.Disclosure on your website seems to indicate the company's lack of lithium use in its
product. However, disclosure in your offering circular seems to indicate that lithium
represents a material aspect of your costs of raw materials. Please revise your offering
circular, wherever applicable, to remedy this inconsistency.
SECURITY OWNERSHIP OF MANAGEMENT AND CERTAIN SECURITYHOLDERS, page
28
5.Please update your beneficial ownership table as of a more recent practicable date.
Also, note 4 to the table indicates Salinity owns no securities, contrary to the information
in the table here and on page 17. Please reconcile.
SECURITIES BEING OFFERED, page 29
6.Please revise this section to describe all conversion features of your Class B Common
Stock.
General
7.Please ensure that the following information in your disclosures are consistent throughout
your filing:
•Number of shares sold and related proceeds received through August 5, 2024 in the
Regulation A offering.
•Amount of maximum net offering proceeds.
8.Please revise your cover page and Summary sections to clarify the amount of securities
being offered by the company and the total amount of bonus shares issuable assuming the
maximum. In this regard, we note your footnote (3) on page 2 states that the 25,000,000
Class A Common Stock outstanding after this offering assumes that the maximum number
of Bonus Shares proposed for issuance in this Offering are issued.
9.On pages 12 and 20, you disclose that the jury trial waiver provision in Exhibits 4.1 and
4.2 applies to claims under the federal securities laws. Please reconcile with the actual
provision included on pages 6 and 7 of those exhibits, which excludes from its scope
claims arising under those laws. Similarly, on pages 12 and 20, you disclose your belief
regarding the applicability of the exclusive forum provision in Exhibits 4.1 and 4.2 to
claims arising under the federal securities laws. However, the actual forum provision on
page 6 of those exhibits appears to specifically exclude from its scope claims arising
under those laws. Please reconcile.
September 10, 2024
Page 3
Exhibit 11.1, page III-1
10.Please include a revised consent that also references the financial statements as of and for
the fiscal year ended December 31, 2022, to be consistent with the financial
statement periods covered in the audit report.
We will consider qualifying your offering statement at your request. If a participant in
your offering is required to clear its compensation arrangements with FINRA, please have
FINRA advise us that it has no objections to the compensation arrangements prior to
qualification.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please contact Eiko Yaoita Pyles at 202-551-3587 or Hugh West at 202-551-3872 if you
have questions regarding comments on the financial statements and related matters. Please
contact Bradley Ecker at 202-551-4985 or Geoffrey Kruczek at 202-551-3641 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing
cc:Andrew Stephenson